Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Alzheimer's Disease

  Free Subscription

Articles published in J Neurol Neurosurg Psychiatry

Retrieve available abstracts of 50 articles:
HTML format

Single Articles

    January 2024
  1. PATEL V, Edison P
    Cardiometabolic risk factors and neurodegeneration: a review of the mechanisms underlying diabetes, obesity and hypertension in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2024 Jan 30:jnnp-2023-332661.
    PubMed     Abstract available

  2. KEUSS SE, Coath W, Cash DM, Barnes J, et al
    Rates of cortical thinning in Alzheimer's disease signature regions associate with vascular burden but not with beta-amyloid status in cognitively normal adults at age 70.
    J Neurol Neurosurg Psychiatry. 2024 Jan 10:jnnp-2023-332067.
    PubMed     Abstract available

    December 2023
  3. YANG T, Xiao Y, Cheng Y, Huang J, et al
    Epigenetic clocks in neurodegenerative diseases: a systematic review.
    J Neurol Neurosurg Psychiatry. 2023;94:1064-1070.
    PubMed     Abstract available

    November 2023
  4. GOLDBERG TE, Lee S, Devanand DP, Schneider LS, et al
    Comparison of relative change with effect size metrics in Alzheimer's disease clinical trials.
    J Neurol Neurosurg Psychiatry. 2023 Nov 18:jnnp-2023-331941.
    PubMed     Abstract available

    October 2023
  5. GRAHAM N, Zimmerman K, Heslegrave AJ, Keshavan A, et al
    Alzheimer's disease marker phospho-tau181 is not elevated in the first year after moderate-to-severe TBI.
    J Neurol Neurosurg Psychiatry. 2023 Oct 13:jnnp-2023-331854.
    PubMed     Abstract available

  6. LI H, Tan CC, Tan L, Xu W, et al
    Predictors of cognitive deterioration in subjective cognitive decline: evidence from longitudinal studies and implications for SCD-plus criteria.
    J Neurol Neurosurg Psychiatry. 2023;94:844-854.
    PubMed     Abstract available

    September 2023
  7. SHINOHARA M, Gheni G, Hitomi J, Bu G, et al
    APOE genotypes modify the obesity paradox in dementia.
    J Neurol Neurosurg Psychiatry. 2023;94:670-680.
    PubMed     Abstract available

  8. DUNNE R, Coulthard E
    Tipping the scales towards routine APOE genotyping.
    J Neurol Neurosurg Psychiatry. 2023;94:669.

    August 2023
  9. CHUN MY, Jang H, Kim SJ, Park YH, et al
    Emerging role of vascular burden in AT(N) classification in individuals with Alzheimer's and concomitant cerebrovascular burdens.
    J Neurol Neurosurg Psychiatry. 2023 Aug 9:jnnp-2023-331603.
    PubMed     Abstract available

    June 2023
  10. SU WM, Gu XJ, Dou M, Duan QQ, et al
    Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2023 Jun 22:jnnp-2023-331142.
    PubMed     Abstract available

  11. COULTHARD E, Hosseini AA
    Blood biomarkers: ready for clinical practice?
    J Neurol Neurosurg Psychiatry. 2023;94:409-410.

  12. LEHMANN S, Schraen-Maschke S, Vidal JS, Delaby C, et al
    Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function.
    J Neurol Neurosurg Psychiatry. 2023;94:411-419.
    PubMed     Abstract available

    April 2023
  13. DAI L, Gao F, Wang Q, Lv X, et al
    Molecules of senescent glial cells differentiate Alzheimer's disease from ageing.
    J Neurol Neurosurg Psychiatry. 2023 Apr 3:jnnp-2022-330743.
    PubMed     Abstract available

  14. ALTOMARE D, Stampacchia S, Ribaldi F, Tomczyk S, et al
    Plasma biomarkers for Alzheimer's disease: a field-test in a memory clinic.
    J Neurol Neurosurg Psychiatry. 2023 Apr 3:jnnp-2022-330619.
    PubMed     Abstract available

  15. VACCHIANO V, Mastrangelo A, Zenesini C, Baiardi S, et al
    Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis.
    J Neurol Neurosurg Psychiatry. 2023 Apr 3:jnnp-2022-330709.
    PubMed     Abstract available

  16. VAN 'T HOOFT JJ, Pelkmans W, Tomassen J, Smits C, et al
    Distinct disease mechanisms may underlie cognitive decline related to hearing loss in different age groups.
    J Neurol Neurosurg Psychiatry. 2023;94:314-320.
    PubMed     Abstract available

    February 2023
  17. HAZAN J, Wing M, Liu KY, Reeves S, et al
    Clinical utility of cerebrospinal fluid biomarkers in the evaluation of cognitive impairment: a systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2023;94:113-120.
    PubMed     Abstract available

    January 2023
  18. JIANG Y, Wan M, Xiao X, Lin Z, et al
    GSN gene frameshift mutations in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2023 Jan 17:jnnp-2022-330465.
    PubMed     Abstract available

    December 2022
  19. O'CONNOR A, Rice H, Barnes J, Ryan NS, et al
    First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer's disease: the Dominantly Inherited Alzheimer's Network Study.
    J Neurol Neurosurg Psychiatry. 2022 Dec 15:jnnp-2022-329843.

  20. HUSAIN M
    Noradrenergic therapies for apathy in Alzheimer's disease?
    J Neurol Neurosurg Psychiatry. 2022 Dec 5:jnnp-2022-330824.

    November 2022
  21. AYTON S, Janelidze S, Kalinowski P, Palmqvist S, et al
    CSF ferritin in the clinicopathological progression of Alzheimer's disease and associations with APOE and inflammation biomarkers.
    J Neurol Neurosurg Psychiatry. 2022 Nov 10. pii: jnnp-2022-330052.
    PubMed     Abstract available

    August 2022
  22. HALBGEBAUER S, Steinacker P, Hengge S, Oeckl P, et al
    CSF levels of SNAP-25 are increased early in Creutzfeldt-Jakob and Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2022 Aug 22. pii: jnnp-2021-328646.
    PubMed     Abstract available

  23. O'CONNOR A, Abel E, Benedet AL, Poole T, et al
    Plasma GFAP in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study.
    J Neurol Neurosurg Psychiatry. 2022 Aug 10. pii: jnnp-2022-329663.

  24. BARBA L, Abu Rumeileh S, Bellomo G, Paolini Paoletti F, et al
    Cerebrospinal fluid beta-synuclein as a synaptic biomarker for preclinical Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2022 Aug 9. pii: jnnp-2022-329124.
    PubMed     Abstract available

    July 2022
  25. DAVID MCB, Del Giovane M, Liu KY, Gostick B, et al
    Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer's disease: systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2022 Jul 5. pii: jnnp-2022-329136.
    PubMed     Abstract available

    June 2022
  26. OVERMAN MJ, Drummond N, Butler CR, Ahmed S, et al
    Tracking the clinical progression of posterior cortical atrophy: implications for post-diagnostic and therapeutic interventions.
    J Neurol Neurosurg Psychiatry. 2022;93:683-684.

  27. PARNETTI L, Paolini Paoletti F, Gaetani L
    Blood biomarkers may distinguish among dementia disorders.
    J Neurol Neurosurg Psychiatry. 2022;93:571.

    April 2022
  28. OECKL P, Anderl-Straub S, Von Arnim CAF, Baldeiras I, et al
    Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion.
    J Neurol Neurosurg Psychiatry. 2022 Apr 27. pii: jnnp-2021-328547.
    PubMed     Abstract available

    March 2022
  29. CHENG L, Li W, Chen Y, Lin Y, et al
    Plasma Abeta as a biomarker for predicting Abeta-PET status in Alzheimer's diseasea systematic review with meta-analysis.
    J Neurol Neurosurg Psychiatry. 2022 Mar 3. pii: jnnp-2021-327864.
    PubMed     Abstract available

  30. KONCZ R, Thalamuthu A, Wen W, Catts VS, et al
    The heritability of amyloid burden in older adults: the Older Australian Twins Study.
    J Neurol Neurosurg Psychiatry. 2022;93:303-308.
    PubMed     Abstract available

    February 2022
  31. LAGARDE J, Olivieri P, Tonietto M, Tissot C, et al
    Tau-PET imaging predicts cognitive decline and brain atrophy progression in early Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2022 Feb 28. pii: jnnp-2021-328623.
    PubMed     Abstract available

    January 2022
  32. CHOULIARAS L, Thomas A, Malpetti M, Donaghy P, et al
    Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy.
    J Neurol Neurosurg Psychiatry. 2022 Jan 25. pii: jnnp-2021-327788.
    PubMed     Abstract available

  33. HALBGEBAUER S, Steinacker P, Verde F, Weishaupt J, et al
    Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS.
    J Neurol Neurosurg Psychiatry. 2022;93:68-74.
    PubMed     Abstract available

    November 2021
  34. ZHOU D, Li A, Li X, Zhuang W, et al
    Effects of 40 Hz transcranial alternating current stimulation (tACS) on cognitive functions of patients with Alzheimer's disease: a randomised, double-blind, sham-controlled clinical trial.
    J Neurol Neurosurg Psychiatry. 2021 Nov 11. pii: jnnp-2021-326885.

  35. ALCOLEA D, Delaby C, Munoz L, Torres S, et al
    Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias.
    J Neurol Neurosurg Psychiatry. 2021;92:1206-1214.
    PubMed     Abstract available

    September 2021
  36. CHONG JR, Ashton NJ, Karikari TK, Tanaka T, et al
    Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances.
    J Neurol Neurosurg Psychiatry. 2021 Sep 11. pii: jnnp-2021-327370.
    PubMed     Abstract available

    June 2021
  37. RAUCHMANN BS, Schneider-Axmann T, Perneczky R
    Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Abeta-PET and cognition.
    J Neurol Neurosurg Psychiatry. 2021 Jun 29. pii: jnnp-2020-325537.
    PubMed     Abstract available

  38. CHEUNG CY, Mok V, Foster PJ, Trucco E, et al
    Retinal imaging in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2021 Jun 9. pii: jnnp-2020-325347.
    PubMed     Abstract available

    April 2021
  39. SINGLETON E, Hansson O, Pijnenburg YAL, La Joie R, et al
    Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2021 Apr 13. pii: jnnp-2020-325497.
    PubMed     Abstract available

    February 2021
  40. OLIVEIRA FPM, Walker Z, Walker RWH, Attems J, et al
    (123)I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease: a new quantitative analysis of autopsy confirmed cases.
    J Neurol Neurosurg Psychiatry. 2021 Feb 4. pii: jnnp-2020-324606.
    PubMed     Abstract available

    December 2020
  41. HALBGEBAUER S, Oeckl P, Steinacker P, Yilmazer-Hanke D, et al
    Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2020 Dec 30. pii: jnnp-2020-324306.
    PubMed     Abstract available

    When hearing loss masquerades as cognitive decline.
    J Neurol Neurosurg Psychiatry. 2020;91:1248.

    November 2020
  43. KEIR LHM, Breen DP
    REM sleep behaviour disorder in patients without synucleinopathy.
    J Neurol Neurosurg Psychiatry. 2020;91:1239-1240.

    October 2020
  44. CHU CS, Li CT, Brunoni AR, Yang FC, et al
    Cognitive effects and acceptability of non-invasive brain stimulation on Alzheimer's disease and mild cognitive impairment: a component network meta-analysis.
    J Neurol Neurosurg Psychiatry. 2020 Oct 28. pii: jnnp-2020-323870.
    PubMed     Abstract available

  45. LU L, Zheng X, Wang S, Tang C, et al
    Anti-Abeta agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2020 Oct 12. pii: jnnp-2020-323497.
    PubMed     Abstract available

  46. KOH W, Lim L, Low A, Wong B, et al
    Development and validation of a brief visual based cognitive screening tool for dementia: the Visual Cognitive Assessment Test short-form (VCAT-S).
    J Neurol Neurosurg Psychiatry. 2020;91:1122-1123.

    September 2020
  47. AGIN A, Blanc F, Bousiges O, Villette C, et al
    Environmental exposure to phthalates and dementia with Lewy bodies: contribution of metabolomics.
    J Neurol Neurosurg Psychiatry. 2020;91:968-974.
    PubMed     Abstract available

  48. BENUSSI A, Karikari TK, Ashton N, Gazzina S, et al
    Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration.
    J Neurol Neurosurg Psychiatry. 2020;91:960-967.
    PubMed     Abstract available

    May 2020
  49. CHEN S, Honda T, Ohara T, Hata J, et al
    Serum homocysteine and risk of dementia in Japan.
    J Neurol Neurosurg Psychiatry. 2020;91:540-546.
    PubMed     Abstract available

  50. SENOVA S, Fomenko A, Gondard E, Lozano AM, et al
    Anatomy and function of the fornix in the context of its potential as a therapeutic target.
    J Neurol Neurosurg Psychiatry. 2020;91:547-559.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.